Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Return on Sales: 2009-2025

Historic Return on Sales for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Sep 2025 value amounting to 0.53%.

  • UNITED THERAPEUTICS's Return on Sales rose 13.00% to 0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year increase of 13.00%. This contributed to the annual value of 0.42% for FY2024, which is 1.00% down from last year.
  • Per UNITED THERAPEUTICS's latest filing, its Return on Sales stood at 0.53% for Q3 2025, which was up 0.21% from 0.53% recorded in Q2 2025.
  • In the past 5 years, UNITED THERAPEUTICS's Return on Sales ranged from a high of 0.56% in Q4 2024 and a low of 0.27% during Q1 2021.
  • Over the past 3 years, UNITED THERAPEUTICS's median Return on Sales value was 0.42% (recorded in 2024), while the average stood at 0.46%.
  • Per our database at Business Quant, UNITED THERAPEUTICS's Return on Sales declined by 10bps in 2021 and then increased by 14bps in 2024.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's Return on Sales stood at 0.28% in 2021, then rose by 9bps to 0.38% in 2022, then increased by 5bps to 0.42% in 2023, then rose by 14bps to 0.56% in 2024, then rose by 13bps to 0.53% in 2025.
  • Its Return on Sales stands at 0.53% for Q3 2025, versus 0.53% for Q2 2025 and 0.54% for Q1 2025.